Inhaled Cannabinoids Versus Immediate-release Oral Opioids for the Management of Breakthrough Cancer Pain
Conditions
- Cancer
- Breakthrough Cancer Pain
Interventions
- DRUG: PPP001
- DRUG: Morphine sulfate or Hydromorphone or Oxycodone
Sponsor
Tetra Bio-Pharma
Collaborators